share_log

BRIEF-Vaxxinity Receives FDA Fast Track Designation For Ub-311 For Treatment Of Alzheimer's Disease

reuters ·  May 2, 2022 09:00

May 2 (Reuters) - Vaxxinity Inc VAXX.O :

* VAXXINITY RECEIVES FDA FAST TRACK DESIGNATION FOR UB-311 FOR TREATMENT OF ALZHEIMER'S DISEASE

* VAXXINITY RECEIVES FDA FAST TRACK DESIGNATION FOR UB-311 FOR TREATMENT OF ALZHEIMER'S DISEASE

Source text for Eikon: ID:nGNXDvWhm Further company coverage: VAXX.O

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment